OPT
Opthea Limited Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website opthea.com
- Employees(FY) 24
- ISIN US68386J2087
Performance
-10.26%
1W
-3.67%
1M
+15.2%
3M
+81.38%
6M
+15.59%
YTD
-10.73%
1Y
Profile
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead product candidate is Sozinibercept (OPT 302), a soluble form of vascular endothelial growth factor receptor-3 VEGFR-3, currently under Phase 3 clinical development as a novel therapy for wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Technical Analysis of OPT 2024-05-10
Overview:
In analyzing the technical indicators for OPT stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potentia...
Recent News & Updates
- 2023-05-07 17:30
- 2023-04-27 17:30
- 2023-03-06 17:00
Opthea Receives A$8.7 million R&D Tax Incentive(Yahoo Finance)
- 2023-03-05 17:00
- 2023-02-12 17:00
- 2023-02-05 17:00
Opthea To Present at SVB Leerink Global Biopharma Conference(Yahoo Finance)
- 2023-01-29 17:00
Opthea To Present at Sequire Biotechnology Conference(Yahoo Finance)
- 2022-12-11 21:08
- 2022-12-09 02:00
- 2022-12-05 17:00
Opthea to Present at the FLORetina 2022 Congress(Yahoo Finance)
- 2022-11-09 17:00
Opthea to Present at Jefferies London Healthcare Conference(Yahoo Finance)
- 2022-10-23 18:00
- 2022-09-18 07:15
Here's Why Opthea (ASX:OPT) Must Use Its Cash Wisely(Yahoo Finance)
- 2022-08-29 18:00
- 2022-08-15 19:46
- 2022-08-14 09:02
- 2022-08-14 09:01
- 2022-06-19 07:05
- 2022-05-10 20:00
Opthea To Present at Upcoming Investor Conferences(Yahoo Finance)
- 2022-05-09 20:20
Opthea Presentation at The Retina World Congress 2022(Yahoo Finance)
- 2022-05-04 18:00
- 2022-04-28 18:00
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting(Yahoo Finance)
- 2022-04-21 20:15
Opthea strengthens its Board of Directors(Yahoo Finance)
- 2022-04-10 08:12
- 2022-03-20 16:00
- 2022-03-09 17:00
- 2022-03-01 17:00
- 2022-02-13 20:06
- 2022-02-13 17:00
- 2022-02-09 17:00